http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2533975-C2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7356715bf92506e532fd65033c1c17ff http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_41ef68d987170096d2e1f1967f9e793f http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cc163eced3a52c31ce6329aaba730bb8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2296a6d8c237c6094654ad75a0faf5d7 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-145 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-02 |
| filingDate | 2013-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2014-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2d0def82584985ec151b61e790e41223 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f64fd37689f2bd53d02cabcefb9320f5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6ba036d331f9624305486e0a2bef231d |
| publicationDate | 2014-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2533975-C2 |
| titleOfInvention | Method for defining form of essential arterial hypertension in children and adolescents |
| abstract | FIELD: medicine. n SUBSTANCE: left ventricular systolic volume as shown by echocardiography is determined in the children and adolescents suffering from essential arterial hypertension; blood serum lead is measured, and a systolic day-time hypertension time index is calculated by a regression analysis formula: SAT TI day-time=0.12+0.0035*SV+0.13*Pb blood serum, wherein SAT TI day-time is the systolic day-time hypertension time index; SV is the left ventricular systolic volume as shown by echocardiography; Pb blood serum is the blood serum lead content. If the systolic day-time hypertension time index falls within the range of 0.25 to 0.50, the form of essential arterial hypertension is considered to be labile, and if the value is more than 0.50, the stable form of essential arterial hypertension is stated. n EFFECT: method enables defining the form of essential arterial hypertension in the children and adolescents by measuring the blood serum lead content as shown by atomic absorption spectrophotometry and determining the left ventricular systolic volume according to echocardiography. n 1 tbl, 3 ex |
| priorityDate | 2013-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 74.